These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
248 related items for PubMed ID: 9687105
1. Intracellular activity of ciprofloxacin and moxifloxacin, a new 8-methoxyquinolone, against methicillin-resistant Staphylococcus aureus. Al-Nawas B, Shah PM. J Antimicrob Chemother; 1998 Jun; 41(6):655-8. PubMed ID: 9687105 [Abstract] [Full Text] [Related]
3. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Entenza JM, Que YA, Vouillamoz J, Glauser MP, Moreillon P. Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359 [Abstract] [Full Text] [Related]
6. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Tarasi A, Cassone M, Monaco M, Tarasi D, Pompeo ME, Venditti M. J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549 [Abstract] [Full Text] [Related]
8. In vitro activity of moxifloxacin, a new 8-methoxyquinolone, against gram-positive bacteria. Malathum K, Singh KV, Murray BE. Diagn Microbiol Infect Dis; 1999 Oct; 35(2):127-33. PubMed ID: 10579093 [Abstract] [Full Text] [Related]
9. Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Ryan BM, Mazzucco CE, Lawrence LE, Ho H, Warr G, Barrett JF, Frosco M. Eur J Clin Microbiol Infect Dis; 2002 Jan; 21(1):27-34. PubMed ID: 11913498 [Abstract] [Full Text] [Related]
10. Antimicrobial efficacy of gatifloxacin and moxifloxacin with and without benzalkonium chloride compared with ciprofloxacin and levofloxacin against methicillin-resistant Staphylococcus aureus. Blondeau JM, Borsos S, Hesje CK. J Chemother; 2007 Apr; 19(2):146-51. PubMed ID: 17434822 [Abstract] [Full Text] [Related]
13. Comparative activity of quinolones (ciprofloxacin, levofloxacin, moxifloxacin and garenoxacin) against extracellular and intracellular infection by Listeria monocytogenes and Staphylococcus aureus in J774 macrophages. Seral C, Barcia-Macay M, Mingeot-Leclercq MP, Tulkens PM, Van Bambeke F. J Antimicrob Chemother; 2005 Apr; 55(4):511-7. PubMed ID: 15731197 [Abstract] [Full Text] [Related]
16. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis. Smith KR, Cobbs CG. Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175 [Abstract] [Full Text] [Related]
19. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin. Bauernfeind A. J Antimicrob Chemother; 1997 Nov; 40(5):639-51. PubMed ID: 9421311 [Abstract] [Full Text] [Related]
20. In-vitro activity of moxifloxacin combined with other antibacterials against methicillin-resistant Staphylococcus aureus. Maggiolo F, Capra R, Bottura P, Pravettoni G, Migliorino M, Suter F. J Chemother; 2000 Jun; 12(3):195-8. PubMed ID: 10877512 [Abstract] [Full Text] [Related] Page: [Next] [New Search]